2 studies found for:    18005144 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study to Test an Approved Product in the Early Treatment of Migraine
Condition: Migraine
Interventions: Drug: MK0462, rizatriptan benzoate / Duration of Treatment: 1day;   Drug: Comparator: placebo / Duration of Treatment: 1 day
2 Completed Study to Test an Approved Product in the Early Treatment of Migraine (0462-065)(COMPLETED)
Condition: Migraine
Interventions: Drug: MK0462, rizatriptan benzoate / Duration of Treatment: 1day;   Drug: Comparator: placebo / Duration of Treatment: 1 day

Indicates status has not been verified in more than two years